169 related articles for article (PubMed ID: 33728946)
21. Distant metastasis in triple-negative breast cancer.
Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF
Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998
[TBL] [Abstract][Full Text] [Related]
22. [Multimodality treatment concepts for metastatic breast cancer].
Heinemann V; Kahlert S; Stemmler HJ
Internist (Berl); 2010 Nov; 51(11):1358-65. PubMed ID: 21107788
[TBL] [Abstract][Full Text] [Related]
23. The treatment of metastasis from renal cell carcinoma.
Khoury S
Prog Clin Biol Res; 1982; 100():541-7. PubMed ID: 7145983
[No Abstract] [Full Text] [Related]
24. [Survival of patients with disseminated small cell cancer of the lungs].
Orel NF; Trofimova NB; Denchik SA; Bychkov MB
Sov Med; 1990; (2):79-81. PubMed ID: 2162574
[No Abstract] [Full Text] [Related]
25. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
26. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicles in the development of organ-specific metastasis.
Urabe F; Patil K; Ramm GA; Ochiya T; Soekmadji C
J Extracell Vesicles; 2021 Jul; 10(9):e12125. PubMed ID: 34295457
[TBL] [Abstract][Full Text] [Related]
28. Metastasis: the seed and soil theory gains identity.
Fokas E; Engenhart-Cabillic R; Daniilidis K; Rose F; An HX
Cancer Metastasis Rev; 2007 Dec; 26(3-4):705-15. PubMed ID: 17786535
[TBL] [Abstract][Full Text] [Related]
29. Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus.
Gu B; España L; Méndez O; Torregrosa A; Sierra A
Carcinogenesis; 2004 Dec; 25(12):2293-301. PubMed ID: 15347599
[TBL] [Abstract][Full Text] [Related]
30. Frequency and prognosis of metastasis to liver, lung, bone and brain from Merkel cell carcinoma.
Xia YJ; Cao DS; Zhao J; Zhu BZ; Xie J
Future Oncol; 2020 Jun; 16(16):1101-1113. PubMed ID: 32314598
[No Abstract] [Full Text] [Related]
31. Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.
Kim SJ; Kim JW; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Kim TY; Seog Heo D; Bang YJ
BMC Cancer; 2010 Aug; 10():448. PubMed ID: 20731845
[TBL] [Abstract][Full Text] [Related]
32. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data.
Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S
Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the Survival Time in the Non-small Cell Lung Cancer Patients with Different Organ Metastasis].
Wu B; Wei S; Tian J; Song X; Hu P; Cui Y
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):105-110. PubMed ID: 30827327
[TBL] [Abstract][Full Text] [Related]
34. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
[TBL] [Abstract][Full Text] [Related]
35. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.
Sevenich L; Bowman RL; Mason SD; Quail DF; Rapaport F; Elie BT; Brogi E; Brastianos PK; Hahn WC; Holsinger LJ; Massagué J; Leslie CS; Joyce JA
Nat Cell Biol; 2014 Sep; 16(9):876-88. PubMed ID: 25086747
[TBL] [Abstract][Full Text] [Related]
36. [Experimental model for cancer metastasis].
Takahashi Y
Gan To Kagaku Ryoho; 1999 Feb; 26(3):401-7. PubMed ID: 10065110
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of distant metastatic sites in stage IV endometrial cancer: A SEER database study of 2948 women.
Liu Y; Chi S; Zhou X; Zhao R; Xiao C; Wang H
Int J Gynaecol Obstet; 2020 Apr; 149(1):16-23. PubMed ID: 31833058
[TBL] [Abstract][Full Text] [Related]
39. [Possibilities of surgical treatment in disseminated breast cancer].
Bozhok AA; Semiglazov VF; Semiglazov VV; Topuzov EE; Klimov NA
Vopr Onkol; 2011; 57(4):427-33. PubMed ID: 22191229
[No Abstract] [Full Text] [Related]
40. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
